A high concentration of serum omega-3 polyunsaturated fatty acids may lead to a lower risk of cardiovascular disease, according to researchers in China.
April 8, 14:00 CET: Experts debate hot issues in NutraIngredients omega-3 forum
Are omega-3 fisheries really under threat? How many functional foods have cracked omega-3 blockbuster status? How is the sector recovering from the ‘Brasky effect’? How are developing markets developing? How is the latest research influencing regulation?...
Danish probiotics player Chr Hansen has launched a patent-pending soft gel that can deliver live probiotics with a two-year shelf life and matched it with a probiotic-omega-3 supplement targeting pregnant women.
Swiss-based DSM Nutritional Products (DNP) has entered the olive-sourced hydroxytyrosol market that has been hot since the European Food Safety Authority (EFSA) issued a rare plant polyphenol health claim approval in 2011.
Mid-last year the chief of Norwegian omega-3 player EPAX told us, “We are the last of the big omega-3 independents.” Soon after US agri-food company FMC had snapped it up for $350m. Here FMC Nutraceuticals general manager Daniel H. Rosenbaum talks through...
Non-members of the International Fishmeal and Fish Oil Organization (IFFO) are able to apply for ‘responsible supply’ (RS) certification, after the body altered its criteria recently.
DSM has delivered a Q3 increase in EBITDA earnings of 27% across all its divisions despite “headwinds” like the ongoing economic flatline in Europe and elsewhere, challenging currency movements and rising ingredient costs.
A Norwegian start-up says its patent pending compression technology has allowed it to commercialise omega-3 powder that can be formulated in hard tablets rather than capsules.
Just got off the phone to Ola Snove, the new(ish) CEO of Aker part-owned Norwegian omega-3 specialist Epax. Wanted to know his view on high-end omega-3 prospects that have attracted BASF and DSM to the sector. His word: “Stellar”.
